RegeneRx Biopharmaceuticals
(OTC) RGRX
RegeneRx Biopharmaceuticals Financials at a Glance
Market Cap
$400
Revenue (TTM)
$76.76K
Net Income (TTM)
$1.69M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
485.14 (High)
Dividend
$0.00
Beta (Volatility)
485.14 (High)
Price
$0.00
Volume
52
Open
$0.00
Price
$0.00
Volume
52
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.16
Dividend
$0.00
Beta (Volatility)
485.14 (High)
Price
$0.00
Volume
52
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.16
RGRX News
RGRX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout RegeneRx Biopharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
2
CEO
J. J. Finkelstein
Website
www.regenerx.comHeadquarters
Rockville, MD 20850, US
RGRX Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-18%
Net Income Margin
-22%
Return on Equity
0%
Return on Capital
8%
Return on Assets
-5%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$400.00
Shares Outstanding
1.50M
Volume
52
Short Interest
0.00%
Avg. Volume
649.131
Financials (TTM)
Gross Profit
$76.76K
Operating Income
$1.40M
EBITDA
$1.40M
Operating Cash Flow
$940.72K
Capital Expenditure
$0.00
Free Cash Flow
$940.72K
Cash & ST Invst.
$290.89K
Total Debt
$1.45M
RegeneRx Biopharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$19.19K
-0.0%
Gross Profit
$19.19K
-0.0%
Gross Margin
100.00%
N/A
Market Cap
$400.00
N/A
Market Cap/Employee
$200.00
N/A
Employees
2
N/A
Net Income
$385.00K
+9.2%
EBITDA
$304.99K
-191718.9%
Quarterly Fundamentals
Net Cash
$1.39M
-386.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$279.69K
-76.6%
Short Term Debt
$1.21M
+3630.2%
Return on Assets
-4.52%
N/A
Return on Invested Capital
8.18%
N/A
Free Cash Flow
$189.33K
+38.2%
Operating Cash Flow
$189.33K
+38.2%